Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

9G0V

Human LTC4 synthase in complex with compound 1

これはPDB形式変換不可エントリーです。
9G0V の概要
エントリーDOI10.2210/pdb9g0v/pdb
関連するPDBエントリー9GOU
分子名称Leukotriene C4 synthase, PALMITIC ACID, DODECYL-BETA-D-MALTOSIDE, ... (5 entities in total)
機能のキーワードltc4s, inhibitor, lyase
由来する生物種Homo sapiens (human)
タンパク質・核酸の鎖数1
化学式量合計19256.80
構造登録者
Srinivas, H. (登録日: 2024-07-08, 公開日: 2025-02-26, 最終更新日: 2025-03-05)
主引用文献Thoma, G.,Miltz, W.,Waelchli, R.,Orain, D.,Spanka, C.,Decoret, O.,Wolf, R.M.,Hurley, B.,Cheung, A.K.,Sandham, D.A.,Honda, A.,Tichkule, R.,Chen, X.,Patel, T.,Labbe-Giguere, N.,Tan, K.L.,Springer, C.,Manchester, J.,Culshaw, A.J.,Hunt, P.,Srinivas, H.,Penno, C.A.,Ferrand, S.,Numao, S.,Schopfer, U.,Jager, P.,Wack, N.,Hasler, F.,Urban, B.,Sindelar, M.,Loetscher, P.,Kiffe, M.,Ren, X.,Nicklin, P.,White, K.,Subramanian, K.,Liu, H.,Growcott, E.J.,Rohn, T.A.
Discovery of GJG057, a Potent and Highly Selective Inhibitor of Leukotriene C4 Synthase.
J.Med.Chem., 68:4721-4742, 2025
Cited by
PubMed Abstract: Leukotriene C4 synthase (LTC4S) is a glutathione -transferase that mediates the biosynthesis of cysteinyl leukotriene C4 (LTC4). Cysteinyl leukotrienes (CysLTs) are lipid mediators that drive type 2 inflammation, bronchoconstriction, and itch. Thus, LTC4S represents an attractive drug target for the treatment of allergic inflammatory diseases, but to date, no LTC4S inhibitor has been tested in patients. Herein, we disclose the discovery and preclinical profiling of the highly selective, oral LTC4S inhibitor GJG057 (compound ), which exhibits 20-fold improved potency (IC = 44 nM) versus clinical candidate AZD9898 (IC = 900 nM) in a human whole blood LTC4 release assay. GJG057 showed efficacy in a murine asthma exacerbation model as well as in a mastoparan-induced skin challenge PK/PD model and was profiled in GLP toxicology studies. Despite its promising properties, GJG057 was not progressed into clinical trials as an oral drug. Its potential as a topical drug is currently being evaluated.
PubMed: 39960261
DOI: 10.1021/acs.jmedchem.4c02897
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.784 Å)
構造検証レポート
Validation report summary of 9g0v
検証レポート(詳細版)ダウンロードをダウンロード

238582

件を2025-07-09に公開中

PDB statisticsPDBj update infoContact PDBjnumon